Search Results - "Nonomiya, Yuma"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Novel pharmacological effects of poly (ADP-ribose) polymerase inhibitor rucaparib on the lactate dehydrogenase pathway by Nonomiya, Yuma, Noguchi, Kohji, Katayama, Kazuhiro, Sugimoto, Yoshikazu

    “…Poly (ADP-ribose) polymerases (PARPs) are involved in various cellular events, including DNA repair. PARP inhibitors including olaparib and rucaparib, have…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Effect of AKT3 expression on MYC‐ and caspase‐8‐dependent apoptosis caused by polo‐like kinase inhibitors in HCT 116 cells by Nonomiya, Yuma, Noguchi, Kohji, Tanaka, Noritaka, Kasagaki, Takahiro, Katayama, Kazuhiro, Sugimoto, Yoshikazu

    Published in Cancer science (01-12-2016)
    “…Polo‐like kinase (PLK) is a cell‐cycle regulator that is overexpressed in several cancer cell types. Polo‐like kinase is considered a novel target for cancer…”
    Get full text
    Journal Article
  4. 4

    Functional Effects of AKT3 on Aurora Kinase Inhibitor-induced Aneuploidy by Noguchi, Kohji, Hongama, Keita, Hariki, Shiori, Nonomiya, Yuma, Katayama, Kazuhiro, Sugimoto, Yoshikazu

    Published in The Journal of biological chemistry (03-02-2017)
    “…The suppression of mitotic Aurora kinases (AURKs) by AURK inhibitors frequently causes cytokinetic failure, leading to polyploidy or aneuploidy, indicating the…”
    Get full text
    Journal Article
  5. 5

    Regorafenib-Induced Hand-Foot Skin Reaction Is More Severe on the Feet Than on the Hands by Nonomiya, Yuma, Yokokawa, Takashi, Kawakami, Kazuyoshi, Kobayashi, Kazuo, Aoyama, Takeshi, Takiguchi, Tomomi, Sugisaki, Takahito, Suzuki, Kenichi, Suenaga, Mitsukuni, Wakatsuki, Takeru, Yamaguchi, Kensei, Sugimoto, Yoshikazu, Hama, Toshihiro

    Published in Oncology research (07-05-2019)
    “…Regorafenib is a multikinase inhibitor for the treatment of metastatic colorectal cancer. Regorafenib-induced hand-foot skin reaction (HFSR) is a common side…”
    Get full text
    Journal Article
  6. 6

    Effect of AKT 3 expression on MYC ‐ and caspase‐8‐dependent apoptosis caused by polo‐like kinase inhibitors in HCT 116 cells by Nonomiya, Yuma, Noguchi, Kohji, Tanaka, Noritaka, Kasagaki, Takahiro, Katayama, Kazuhiro, Sugimoto, Yoshikazu

    Published in Cancer science (01-12-2016)
    “…Polo‐like kinase ( PLK ) is a cell‐cycle regulator that is overexpressed in several cancer cell types. Polo‐like kinase is considered a novel target for cancer…”
    Get full text
    Journal Article